Skip to main content
Log in

Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 23 June 2023

The Original Article was published on 01 April 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. El Hassani M, Marsot A. External evaluation of population pharmacokinetic models for precision dosing: current state and knowledge gaps. Clin Pharmacokinet. 2023;62:533–40. https://doi.org/10.1007/s40262-023-01233-7.

    Article  PubMed  Google Scholar 

  2. Chung E, Sen J, Patel P, Seto W. Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review. Clin Pharmacokinet. 2021;60:985–1001.

    Article  CAS  PubMed  Google Scholar 

  3. Aljutayli A, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part I: in adults. Clin Pharmacokinet. 2020;59:671–98.

    Article  PubMed  Google Scholar 

  4. Aljutayli A, El-Haffaf I, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients. Clin Pharmacokinet. 2022;61:47–70.

    Article  CAS  PubMed  Google Scholar 

  5. Chen N, Guo J, Xie J, Xu M, Hao X, Ma K, et al. Population pharmacokinetics of polymyxin B: a systematic review. Ann Transl Med. 2022;10:231.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Li ZR, Wang CY, Zhu X, Jiao Z. Population pharmacokinetics of levetiracetam: a systematic review. Clin Pharmacokinet. 2021;60:305–18.

    Article  CAS  PubMed  Google Scholar 

  7. Zamir A, Hussain I, Ur Rehman A, Ashraf W, Imran I, Saeed H, et al. Clinical pharmacokinetics of metoprolol: a systematic review. Clin Pharmacokinet. 2022;61:1095–114.

    Article  CAS  PubMed  Google Scholar 

  8. Qin Y, Zhang LL, Ye YR. Parametric population pharmacokinetics of linezolid: a systematic review. Br J Clin Pharmacol. 2022;88:4043–66.

    Article  CAS  PubMed  Google Scholar 

  9. Muda MR, Harun SN, Syed Sulaiman SA, Sheikh Ghadzi SM. Population pharmacokinetics analyses of rifampicin in adult and children populations: a systematic review. Br J Clin Pharmacol. 2022;88:3132–52.

    Article  PubMed  Google Scholar 

  10. Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet. 2012;51:515–25.

    Article  CAS  PubMed  Google Scholar 

  11. Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z. Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations. Clin Pharmacokinet. 2021;60:53–68.

    Article  CAS  PubMed  Google Scholar 

  12. Hughes JH, Tong DMH, Faldasz JD, Frymoyer A, Keizer RJ. Evaluation of neonatal and paediatric vancomycin pharmacokinetic models and the impact of maturation and serum creatinine covariates in a large multicentre data set. Clin Pharmacokinet. 2023;62:67–76.

    Article  CAS  PubMed  Google Scholar 

  13. Jiao Z. Basic population pharmacokinetic and pharmacodynamic analysis. 3rd ed. Beijing: Science Press; 2020.

    Google Scholar 

  14. Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, et al. Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement. Clin Pharmacokinet. 2015;54:783–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meng Lv.

Ethics declarations

Funding

This work was supported by Scientific and Technological Project in Henan Province (no. 202102310396 and no. 232102311075).

Conflict of interest

Meng Lv and Shengnan Zhang declare no potential conflicts of interest that might be relevant to this work.

Ethics approval

Not applicable.

Availability of data material and code

Data and code sharing was not applicable to this article as no datasets were generated or analysed during this work.

Author contributions

Meng Lv and Shengnan Zhang contributed to the conception of this letter. The letter was drafted by Meng Lv and Shengnan Zhang, and critically revised by Meng Lv.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Code availability

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, M., Zhang, S. Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”. Clin Pharmacokinet 62, 1183–1185 (2023). https://doi.org/10.1007/s40262-023-01271-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-023-01271-1

Navigation